Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.530
-0.180 (-4.85%)
At close: Mar 18, 2026, 4:00 PM EDT
3.580
+0.050 (1.42%)
After-hours: Mar 18, 2026, 7:58 PM EDT

Prime Medicine Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
63.03182.4841.57187.62185.42
Short-Term Investments
114.657.9780.09106.384.2
Cash & Short-Term Investments
177.68190.44121.67293.92269.62
Cash Growth
-6.70%56.53%-58.61%9.01%405.59%
Other Current Assets
3.6121.4421.312.70.96
Total Current Assets
181.29211.89142.98296.62270.58
Net Property, Plant & Equipment
146.7571.5636.648.5515.68
Other Long-Term Assets
14.6914.0614.2815.1415.6
Total Assets
342.73297.51193.85360.31301.86
Accounts Payable
8.8911.3519.544.331.44
Accrued Expenses
12.615.914.1110.6937.19
Current Portion of Leases
8.143.619.2811.697.34
Unearned Revenue
7.827.09---
Other Current Liabilities
--13.5-12.02
Total Current Liabilities
37.4537.9656.4226.7157.98
Long-Term Leases
108.2937.184.3617.053.07
Other Long-Term Liabilities
76.1369.22-0.281.24
Total Long-Term Liabilities
184.42106.44.3617.334.31
Total Liabilities
221.87144.3660.7844.0462.3
Common Stock
00000
Additional Paid-in Capital
1,009840.36624.41609.8515.16
Accumulated Other Comprehensive Income
0.080-0.02-0.38-0.03
Retained Earnings
-888.35-687.21-491.33-293.2-171.38
Total Common Shareholders' Equity
120.87153.15133.07316.27-156.24
Minority Interest
----395.8
Shareholders' Equity
120.87153.15133.07316.27239.56
Total Liabilities & Equity
342.73297.51193.85360.31301.86
Total Debt
116.4340.7913.6328.7510.41
Net Cash (Debt)
61.25149.65108.03265.18259.21
Net Cash Growth
-59.07%38.52%-59.26%2.30%386.07%
Net Cash Per Share
0.411.261.197.8219.98
Book Value
120.87153.15133.07316.27-156.24
Book Value Per Share
0.811.291.469.33-12.04
Tangible Book Value
120.87153.15133.07316.27-156.24
Tangible Book Value Per Share
0.811.291.469.33-12.04
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q